<?xml version="1.0" encoding="UTF-8"?>
<ref id="ddr21709-bib-0016">
 <mixed-citation publication-type="miscellaneous" id="ddr21709-cit-0016">
  <string-name>
   <surname>Bzówka</surname>, 
   <given-names>M.</given-names>
  </string-name>, 
  <string-name>
   <surname>Mitusińska</surname>, 
   <given-names>K.</given-names>
  </string-name>, 
  <string-name>
   <surname>Raczyńska</surname>, 
   <given-names>A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Samol</surname>, 
   <given-names>A.</given-names>
  </string-name>, 
  <string-name>
   <surname>Tuszyński</surname>, 
   <given-names>J.</given-names>
  </string-name>, &amp; 
  <string-name>
   <surname>Góra</surname>, 
   <given-names>A.</given-names>
  </string-name> (
  <year>2020</year>). Molecular dynamics simulations indicate the COVID‐19 Mpro is not a viable target for small‐molecule inhibitors design. bioRxiv 2020.2002.2027.968008. 
  <pub-id pub-id-type="doi">10.1101/2020.02.27.968008%J</pub-id>
 </mixed-citation>
</ref>
